SV2004001227A - Uso de compuestos en un inhalador de polvo seco ref. pcs22028 - Google Patents
Uso de compuestos en un inhalador de polvo seco ref. pcs22028Info
- Publication number
- SV2004001227A SV2004001227A SV2002001227A SV2002001227A SV2004001227A SV 2004001227 A SV2004001227 A SV 2004001227A SV 2002001227 A SV2002001227 A SV 2002001227A SV 2002001227 A SV2002001227 A SV 2002001227A SV 2004001227 A SV2004001227 A SV 2004001227A
- Authority
- SV
- El Salvador
- Prior art keywords
- compounds
- pcs22028
- ref
- dry powder
- powder inhaler
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940112141 dry powder inhaler Drugs 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 239000002131 composite material Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA FOMULACION DE INHALACION QUE COMPRENDE UN COMPUESTO SELECCIONADO ENTRE UNA CLASE PARTICULAR DE 5, 6-DIHIDRO-9H-PIRAZOLO [3,4-c]-1,2,4-TRIAZOLO [4,3-a] PIRIDINAS, QUE ES CAPAZ DE LIBERAR EL COMPUESTO EN FORMA DE PARTICULAS SOLIDAS FINAS EN EL PULMON , Y AL USO DE TAL FORMULACION EN EL TRATAMIENTO DE CIERTAS ENFERMEDADES TALES COMO LAS ENFERMEDADES RESPIRATORIAS. POR MEDIO DEL USO DE TALES FOMULACIONES ES POSIBLE ELIMINAR LA RESPUESTA DE TOS INDESEADA ASOCIADA CON EL USO DE ESTOS COMPUESTOS EN INHALADORES DE DOSIS MEDIDA DE SOLUCION , PUDIENDO EFECTAR NEGATICAMENTE TAL RESPUESTA A LA ADMINISTRACION DE UNA DOSIS TERAPEUTICAMENTE EFICAZ Y , A LARGO PLAZO, IMPEDIR EL CUMPLIMIENTO DEL TRATAMIENTO POR PARTE DEL PACIENTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0122031.8A GB0122031D0 (en) | 2001-09-12 | 2001-09-12 | Use of pde4 inhibitors in a dry powder inhaler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2004001227A true SV2004001227A (es) | 2004-02-24 |
Family
ID=9921954
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2002001227A SV2004001227A (es) | 2001-09-12 | 2002-09-12 | Uso de compuestos en un inhalador de polvo seco ref. pcs22028 |
| SV2002001226A SV2004001226A (es) | 2001-09-12 | 2002-09-12 | Uso de una combinacion de compuestos en un inhalador de polvo seco, ref. pcs 25280 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2002001226A SV2004001226A (es) | 2001-09-12 | 2002-09-12 | Uso de una combinacion de compuestos en un inhalador de polvo seco, ref. pcs 25280 |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US20030064031A1 (es) |
| EP (1) | EP1427414A1 (es) |
| JP (1) | JP2005505560A (es) |
| KR (1) | KR20040036940A (es) |
| CN (1) | CN1553801A (es) |
| AP (2) | AP2002002624A0 (es) |
| AR (2) | AR036473A1 (es) |
| BG (1) | BG108569A (es) |
| BR (1) | BR0212449A (es) |
| CA (1) | CA2457717A1 (es) |
| CZ (1) | CZ2004310A3 (es) |
| EA (1) | EA006742B1 (es) |
| EC (1) | ECSP045018A (es) |
| EE (1) | EE200400078A (es) |
| GB (1) | GB0122031D0 (es) |
| HN (2) | HN2002000253A (es) |
| HR (1) | HRP20040162A2 (es) |
| HU (1) | HUP0401890A3 (es) |
| IL (1) | IL160380A0 (es) |
| IS (1) | IS7151A (es) |
| MA (1) | MA27062A1 (es) |
| MX (1) | MXPA04002354A (es) |
| NO (1) | NO20041011L (es) |
| NZ (1) | NZ530929A (es) |
| OA (1) | OA12660A (es) |
| PA (2) | PA8554701A1 (es) |
| PE (2) | PE20030443A1 (es) |
| PL (1) | PL368736A1 (es) |
| SK (1) | SK1272004A3 (es) |
| SV (2) | SV2004001227A (es) |
| TN (1) | TNSN04040A1 (es) |
| TW (1) | TW200602054A (es) |
| WO (2) | WO2003022275A1 (es) |
| ZA (1) | ZA200401002B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7931022B2 (en) | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
| KR20050088242A (ko) * | 2002-12-31 | 2005-09-02 | 넥타르 테라퓨틱스 | 진균 감염 요법을 위한 에어로졸화가능한 약제학적 제형물 |
| GB0315889D0 (en) * | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| US20060009435A1 (en) * | 2004-06-23 | 2006-01-12 | Joseph Kaspi | Synthesis and powder preparation of fluticasone propionate |
| JP2009509980A (ja) * | 2005-09-28 | 2009-03-12 | メルク フロスト カナダ リミテツド | 篩分けされたラクトースを含むエアゾール粉末製剤 |
| GB0801876D0 (en) * | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| TR200909788A2 (tr) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu |
| US8834931B2 (en) | 2009-12-25 | 2014-09-16 | Mahmut Bilgic | Dry powder formulation containing tiotropium for inhalation |
| CN105121439A (zh) | 2013-02-19 | 2015-12-02 | 辉瑞公司 | 作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物 |
| KR20150076005A (ko) | 2013-12-26 | 2015-07-06 | 삼성디스플레이 주식회사 | 액정 표시 장치 |
| WO2016012896A1 (en) | 2014-07-24 | 2016-01-28 | Pfizer Inc. | Pyrazolopyrimidine compounds |
| AP2017009744A0 (en) | 2014-08-06 | 2017-02-28 | Pfizer | Imidazopyridazine compounds |
| LT3494962T (lt) * | 2014-09-15 | 2021-07-26 | Verona Pharma Plc | Skysta inhaliavimo kompozicija, apimanti rpl554 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282167B6 (sk) * | 1995-06-06 | 2001-11-06 | Pfizer Inc. | Tricyklické 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a] pyridíny a farmaceutický prostriedok na ich báze |
| US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| DE19835346A1 (de) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
-
2001
- 2001-09-12 GB GBGB0122031.8A patent/GB0122031D0/en not_active Ceased
-
2002
- 2002-09-02 KR KR10-2004-7003619A patent/KR20040036940A/ko active IP Right Grant
- 2002-09-02 HU HU0401890A patent/HUP0401890A3/hu unknown
- 2002-09-02 IL IL16038002A patent/IL160380A0/xx unknown
- 2002-09-02 OA OA1200400071A patent/OA12660A/en unknown
- 2002-09-02 SK SK127-2004A patent/SK1272004A3/sk not_active Application Discontinuation
- 2002-09-02 PL PL02368736A patent/PL368736A1/xx not_active Application Discontinuation
- 2002-09-02 NZ NZ530929A patent/NZ530929A/en unknown
- 2002-09-02 CN CNA028178874A patent/CN1553801A/zh active Pending
- 2002-09-02 WO PCT/IB2002/003599 patent/WO2003022275A1/en not_active Application Discontinuation
- 2002-09-02 JP JP2003526404A patent/JP2005505560A/ja not_active Withdrawn
- 2002-09-02 CA CA002457717A patent/CA2457717A1/en not_active Abandoned
- 2002-09-02 EA EA200400301A patent/EA006742B1/ru not_active IP Right Cessation
- 2002-09-02 EP EP02767763A patent/EP1427414A1/en not_active Withdrawn
- 2002-09-02 MX MXPA04002354A patent/MXPA04002354A/es not_active Application Discontinuation
- 2002-09-02 EE EEP200400078A patent/EE200400078A/xx unknown
- 2002-09-02 CZ CZ2004310A patent/CZ2004310A3/cs unknown
- 2002-09-02 WO PCT/IB2002/003598 patent/WO2003022279A1/en not_active Application Discontinuation
- 2002-09-02 BR BR0212449-1A patent/BR0212449A/pt not_active IP Right Cessation
- 2002-09-05 US US10/236,551 patent/US20030064031A1/en active Pending
- 2002-09-05 US US10/236,228 patent/US20030064034A1/en not_active Abandoned
- 2002-09-10 AR ARP020103426A patent/AR036473A1/es unknown
- 2002-09-10 PE PE2002000894A patent/PE20030443A1/es not_active Application Discontinuation
- 2002-09-10 AR ARP020103427A patent/AR036474A1/es unknown
- 2002-09-10 PE PE2002000893A patent/PE20030509A1/es not_active Application Discontinuation
- 2002-09-11 TW TW094130352A patent/TW200602054A/zh unknown
- 2002-09-11 HN HN2002000253A patent/HN2002000253A/es unknown
- 2002-09-12 PA PA20028554701A patent/PA8554701A1/es unknown
- 2002-09-12 PA PA20028554601A patent/PA8554601A1/es unknown
- 2002-09-12 SV SV2002001227A patent/SV2004001227A/es not_active Application Discontinuation
- 2002-09-12 SV SV2002001226A patent/SV2004001226A/es not_active Application Discontinuation
- 2002-09-12 AP APAP/P/2002/002624A patent/AP2002002624A0/en unknown
- 2002-09-12 AP APAP/P/2002/002623A patent/AP2002002623A0/en unknown
- 2002-10-11 HN HN2002000254A patent/HN2002000254A/es unknown
-
2004
- 2004-02-06 ZA ZA200401002A patent/ZA200401002B/en unknown
- 2004-02-09 BG BG108569A patent/BG108569A/bg unknown
- 2004-02-13 IS IS7151A patent/IS7151A/is unknown
- 2004-02-19 HR HR20040162A patent/HRP20040162A2/xx not_active Application Discontinuation
- 2004-02-26 MA MA27550A patent/MA27062A1/fr unknown
- 2004-03-10 TN TNP2004000040A patent/TNSN04040A1/fr unknown
- 2004-03-10 NO NO20041011A patent/NO20041011L/no not_active Application Discontinuation
- 2004-03-12 EC EC2004005018A patent/ECSP045018A/es unknown
-
2005
- 2005-06-13 US US11/152,741 patent/US20050232871A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2004001227A (es) | Uso de compuestos en un inhalador de polvo seco ref. pcs22028 | |
| UY28908A1 (es) | Dispositivo inhalador de medicamentos | |
| CO5611174A2 (es) | Inhalador de polvo seco | |
| SE0402976D0 (sv) | A medical product | |
| CO5060522A1 (es) | Administracion de un agente activo en aerosol | |
| MX9700034A (es) | Formulacion para la aplicacion por inhalacion. | |
| CY1107315T1 (el) | Φαρμακευτικα σκευασματα για εισπνεομενα ξηρας σκονης υπο μορφη σκληρων σβωλων | |
| MX2010008234A (es) | Nueva dosificacion y formulacion. | |
| AR022886A1 (es) | Utilizacion de xenon o mezclas de gas xenon composicion para el tratamiento de intoxicaciones neurologicas y procedimiento para la preparacion de un medicamento inhalable | |
| EE200000376A (et) | Imemistoru ja seda sisaldav inhalaator | |
| AR057527A2 (es) | Disposicion desaglomeradora para desaglomerar un medicamento en polvo | |
| AR039947A1 (es) | Formulacion farmaceutica que comprende nicotina | |
| WO2006008517A3 (en) | Use of dry powder compositions for pulmonary delivery | |
| MY177027A (en) | Novel dosage and formulation | |
| BRPI0511136A (pt) | formulações em pó para inalação contendo beta-agonistas enantiÈmeros puros | |
| WO2010011329A3 (en) | The delivery of powdered drug via inhalation | |
| US20200360124A1 (en) | Teeth whitening device | |
| ECSP14028814A (es) | Nueva forma de dosificación y formulación de abediterol | |
| AR100368A1 (es) | Tratamiento de trastornos respiratorios | |
| IL212369A0 (en) | A metered dose inhaler comprising a canister containing an aerosol formulation comprising levalbuterol l-tartrate, and use of levalbuterol l-tartrate in the manufacture of said metered dose inhaler for treating bronchospasm. | |
| CY1117596T1 (el) | Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης | |
| MX2021011491A (es) | Polvos secos inhalables. | |
| DOP2002000454A (es) | Uso de una combinacion de compuesto en un inhalador de polvo seco. | |
| CR7270A (es) | Uso de compuestos en un inhalador de polvo seco | |
| AR047154A1 (es) | Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |